Patents Assigned to Immunogenics LLC
  • Patent number: 10434150
    Abstract: Oral administration of ALV003 can protect celiac disease patients and patients otherwise suffering from gluten-intolerance from the harmful effects of ingesting food containing gluten.
    Type: Grant
    Filed: January 23, 2014
    Date of Patent: October 8, 2019
    Assignee: Immunogenics LLC
    Inventors: Bret Berner, Matthew John Siegel
  • Patent number: 9993531
    Abstract: Pharmaceutical formulations of orally administered proteins can be stabilized from oxidative degradation and inactivation in the stomach and GI tract by the addition of an antioxidant.
    Type: Grant
    Filed: February 16, 2016
    Date of Patent: June 12, 2018
    Assignee: Immunogenics LLC
    Inventors: Matthew J. Siegel, Bret Berner